维普中文期刊产品整合服务
647篇 您的检索式:作者名="Prieto J"
    题名 作者 年代 出处 被引量
1Nat Genet:单基因突变导致过敏性皮炎的发生显示文摘最近,研究者们鉴定出了一类导致神经性皮炎发生的关键基因突变:CARDll。来自美国NIH过敏与传染病研究所的研究者们通过对四个没有血缘关系的患病家庭进行分析,发现了这一导致疾病产生的基因、Chi A Ma, Yuan Zhang, Michael A Weinreich, Jonathan J Lyons, Celeste G Nelson, Thomas DiMaggio, Kelly D Stone, Joshua D Milner Jeffrey R Stinson, Elisa Ruffo, Batsukh Dorjbal, Swadhinya Arjunaraja, Kelsey Voss, Andrew L Snow Jordan K Abbott, Pia J Hauk, Paul R Reynolds, Erwin W Gelfand Elisa Ruffo Salomé Glauzy, Natsuko Yamakawa, Eric Meffre Jennifer Stoddard, Julie Niemela, Sergio D Rosenzweig Yu Zhang, Helen F Matthews Joshua J McElwee Nina Jones Alejandro Palma, Matías Oleastro, Emma Prieto, Andrea R Bernasconi, Geronimo Dubra, Silvia Danielian, Jonathan Zaiat, Marcelo A Marti Brian Kim Megan A Cooper Neil Romberg 2017现代生物医学进展2017,17,27:3
2Endoscopic and anesthetic feasibility of EUS and ERCP combined in a single session versus two different sessions显示文摘AIM:To discuss the feasibility of single session endoscopic ultrasonography(EUS) to discuss and endoscopic retrograde cholangiopancreatography(ERCP) execution.METHODS:Retrospective endoscopic and anesthetic outcome comparison of performing both EUS and ERCP in a single endoscopic session(Group Ⅰ) versus performing each procedure in two different sessions(Group Ⅱ) was made.The following variables were evaluated:epidemiological variables,American Society of Anesthesiologists Physical Status Classification(ASA) level,procedural time,propofol dose,anesthetic complications,endoscopic complications and diagnostic yield,and therapeutic procedures on both groups.T-student,ChiSquare and Fisher test were used for comparison.RESULTS:We included 39 patients in Group Ⅰ(mean age:69.85 ± 9.25;27 men) and 46 in Group Ⅱ(mean age:67.46 ± 12.57;25 men).Procedural time did not differ significantly between both groups(Group Ⅰvs Group Ⅱ:93 ± 32.78 vs 98.98 ± 38.17;P >0.05) but the dose of propofol differed(Group Ⅰ vs Group Ⅱ:322.28 ± 250.54 mg vs 516.96 ± 289.06 mg;P = 0.001).Three patients had normal findings on both explorations.Three anesthetic complications [O2 desaturation(2),broncoaspiration(1)] and 9 endoscopic complications [pancreatitis(6),bleeding(1),perforation(1),cholangitis(1)] occurred without significant differences between both groups(P > 0.05).We did not find any significant difference regarding age,sex,ASA scale level,diagnostic yield or therapeutic maneuvers between both groups.CONCLUSION:The performance of EUS and ERCP in a single session offers a similar diagnostic and therapeutic yield,does not entail a higher complication risk and requires a significantly smaller dose of propofol for sedation compared with performing each exploration in a different session.Juan J Vila Marcos Kutz Silvia Goi Miriam Ostiz Edurne Amorena Carlos Prieto Cristina Rodriguez Ignacio Fernández-Urien Francisco J Jiménez 2011World Journal of Gastrointestinal Endoscopy2011,3,3:3
3Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure显示文摘Hepatitis B virus(HBV) is one of the most significant hepatocarcinogens. The ultimate goal of anti-HBV treatment is to prevent the development of hepatocellular carcinoma(HCC). During the last two decades, with the use of currently available anti-HBV therapies(lamivudine, entecavir and tenofovir disoproxil fumatate), there has been a decrease in the incidence of HBVassociated HCC(HBV-HCC). Furthermore, several studies have demonstrated a reduction in recurrent or new HCC development after initial HCC tumor ablation. However, during an observation period spanning 10 to 20 years, several case reports have demonstrated the development of new, subsequent new and recurrent HCC even in patients with undetectable serum HBV DNA. The persistent risk for HCC is attributed to the presence of covalently closed circular DNA(cccDNA) in the hepatocyte nucleus which continues to work as a template for HBV replication. While a functional cure(loss of hepatitis B surface antigen and undetectable viral DNA) can be attained with nucleos(t)ide analogues, these therapies do not eliminate cccDNA. Of utmost importance is successful eradication of the transcriptionally active HBV cccDNA from hepatocyte nuclei which would be considered a complete cure. The unpredictable nature of HCC development in patients with chronic HBV infection shows the need for a complete cure. Continued support and encouragement for research efforts aimed at developing curative therapies is imperative. The aims of this minireview are to highlight these observations and emphasize the need for a cure for HBV.Brianna J Shinn Aaron Martin Robert M Coben Mitchell I Conn Jorge Prieto Howard Kroop Anthony J DiMarino Hie-Won Hann 2019World Journal of Hepatology2019,11,1:3
4Reversible and athermal photo-vitrification of As50 ·Se50 thin films deposited onto silicon wafer and glass substrates 显示文摘PRIETO - ALCON R MARQUEZ E GONZALEZ- LEAL J M 1999Appl Phys A1999,68,:2
5Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes 显示文摘Guillen J de Ahneida RF Prieto M 2009Mol Membr Biol2009,26,4:1
6Biochemical traits and antimicrobial susceptibility of Streptococcus suis isolated from slaughtered pigs显示文摘Prieto C Garcia F J Suarez P 1994J Vet Med1994,41,9:1
7Isolation,purification,and characterization of a cold-active lipase from Aspergillus nidulans显示文摘Mayordomo I Randez-Gil F Prieto J A 2000J Agric Food Chem2000,48,1:1
8Potential use of near infrared reflectance spectroscopy (NIRS) for the estimation of chemical composition of oxen meat samples显示文摘Prieto N Andr6s S Gir/:ldez F J 2006Meat Science2006,74,3:1
9A new minimal approach in cochlear implant surgery:the Colombian experience显示文摘Almario J Lora J Prieto J 2005Otolaryngol Head Neck Surg2005,133,:1
10Environmental efficiency and regulatory standards:the case of CO2 emissions from OECD industries显示文摘ZOFIO J L PRIETO A M 2001Resource and Energy Economics2001,23,1:1
11Isolation, purification and characterization of a cold-active lipase from Aspergillus nidulans 显示文摘Mayordomo I Randez-Gil F Prieto J A 2000J Agric Food Chem2000,48,:1
12The phytotoxic activity of some metabolites of Botrytis cinerea 显示文摘Rebordinos L Cantoral J M Prieto M V 1996Phytochemistry1996,42,:1
13Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocation显示文摘Prieto J Lensmar C Roquet A 2000Respir Med2000,94,:1
14Effects of intense pulsed light on sun-damaged human skin:routine,and ultrastructural analysis显示文摘Prieto VG Sadick NS Lloreta J 2002Lasers Surg Med2002,30,:1
15Abnormal gamma- IFN and alpha-TNF secretion in purified CD2^+ cells from autoimmune thrombocytopenic purpua (ATP) patient : their implication in the clinical course of the disease显示文摘GARCIA-SUAREZ J PRIETO A REYES E 1995Am H Hematol1995,49,4:1
16Determination of fipronil by solid-phase microextraction and gas chromatography-mass spectrometry 显示文摘Vilchez J L Prieto A Araujo L 2001Journal of Chromatography A2001,919,1:1
17Single phase power factor correction: a survey显示文摘Garcia O Cobos J A Prieto R 2003IEEE Transactions on Power Electronics2003,18,3:1
18Differential-pulse adsorptive stripping voltammetric determination of the antibacterial lomefloxzcin显示文摘 ARAUJO L PRIETO A 2001J Phar and Biome Anal2001,26,1:1
19Loss of Mda-7 expression with progression of melanoma显示文摘Ellerhorst J A Prieto V G Ekmekcioglu S 2002J Clin Oncol2002,20,4:1
20Statistical evaluation of mathematical models for microbial growth Intematonal显示文摘S Lopez M prieto J Dijkstra 2004Jourmal of Food Microbiology2004,96,:1
返回顶部 每页显示:
共33页 首页 上一页 第1页 下一页 末页 /33 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费